Ledger.Open graph →

SEC Form D · Amendment · filed April 21, 2025

Averna Therapeutics Inc

Offering

$85.0M

Sold

$43.8M

Exemption

Rule 506(b)

Industry

Other Health Care

Location

WATERTOWN, MA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Henry Chen · Mountain View, CADirector Roy Amariglio · New York, NYDirector Dylan Morris · San Fransicso, CADirector Stephen Squinto · Woodbridge, CTDirector Tal Zaks, M.D., Ph.D · New York, NYExec · Director Raju Prasad, Ph.D · Watertown, MADirector Thomas Barnes, Ph.D · Watertown, MAExec · Director Aaron Nelson · Sheridan, WYDirector Anat Nursella · New York, NYExec Tal Zaks, M.D., Ph.D · New York, NYExec · Director Raju Prasad, Ph.D · Watertown, MADirector Thomas Barnes, Ph.D · Watertown, MAExec · Director Henry Chen · Sunnyvale, CADirector Roy Amariglio · New York, NYDirector Dylan Morris · Palo Alto, CADirector Stephen Squinto · HANOVER, NHDirector Aaron Nelson · Sheridan, WYDirector Anat Nursella · New York, NYExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗